- Home
- ORIC vs BCSF Comparison
ORIC vs BCSF Comparison
Compare ORIC & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- BCSF
- Stock Information
- Founded
- ORIC 2014
- BCSF 2015
- Country
- ORIC United States
- BCSF United States
- Employees
- ORIC N/A
- BCSF N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- BCSF Finance/Investors Services
- Sector
- ORIC Health Care
- BCSF Finance
- Exchange
- ORIC Nasdaq
- BCSF Nasdaq
- Market Cap
- ORIC 1.1B
- BCSF 983.4M
- IPO Year
- ORIC 2020
- BCSF 2018
- Fundamental
- Price
- ORIC $14.19
- BCSF $13.41
- Analyst Decision
- ORIC Strong Buy
- BCSF Buy
- Analyst Count
- ORIC 8
- BCSF 2
- Target Price
- ORIC $16.57
- BCSF $16.50
- AVG Volume (30 Days)
- ORIC 1.6M
- BCSF 443.2K
- Earning Date
- ORIC 11-11-2025
- BCSF 11-04-2025
- Dividend Yield
- ORIC N/A
- BCSF 13.43%
- EPS Growth
- ORIC N/A
- BCSF N/A
- EPS
- ORIC N/A
- BCSF 1.66
- Revenue
- ORIC N/A
- BCSF $283,687,000.00
- Revenue This Year
- ORIC N/A
- BCSF N/A
- Revenue Next Year
- ORIC N/A
- BCSF N/A
- P/E Ratio
- ORIC N/A
- BCSF $8.06
- Revenue Growth
- ORIC N/A
- BCSF N/A
- 52 Week Low
- ORIC $3.90
- BCSF $13.20
- 52 Week High
- ORIC $14.93
- BCSF $19.21
- Technical
- Relative Strength Index (RSI)
- ORIC 71.68
- BCSF 23.01
- Support Level
- ORIC $13.85
- BCSF $13.62
- Resistance Level
- ORIC $14.93
- BCSF $14.37
- Average True Range (ATR)
- ORIC 0.81
- BCSF 0.31
- MACD
- ORIC 0.35
- BCSF -0.08
- Stochastic Oscillator
- ORIC 85.29
- BCSF 3.04
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.